Basaglar and Mounjaro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Basaglar (insulin glargine) and Mounjaro (tirzepatide). Common drug interactions include joint swelling among females and blood glucose decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Basaglar and Mounjaro. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Mounjaro?

Mounjaro has active ingredients of tirzepatide. It is often used in weight loss. eHealthMe is studying from 37,669 Mounjaro users. Check the latest studies of Mounjaro.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

85 people who take Basaglar and Mounjaro together, and have interactions are studied.

Basaglar and Mounjaro drug interactions.

What are the common drug interactions of Basaglar and Mounjaro, by gender? *:

female:

Joint swelling
Myalgia (muscle pain)
Oral disorder (mouth disease)
Psychotic disorder
Pulmonary embolism (blockage of the main artery of the lung)
Rash
Staphylococcal infection (an infection with staphylococcus bacteria)
Swelling face
Throat tightness
Blood glucose increased

male:

Blood glucose decreased
Blood glucose increased
Constipation
Flatulence (flatus expelled through the anus)
Nausea (feeling of having an urge to vomit)
Stress
Eructation (release of gas from the digestive tract)
Weight increased
Arthropathy
Irritable bowel syndrome

What are the common drug interactions of Basaglar and Mounjaro, by age (0-1 to 60+)? *:

0-1:

Abdominal pain upper
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Vomiting

2-9:

n/a

10-19:

n/a

20-29:

Vomiting
Diarrhoea
Gait disturbance
Nausea (feeling of having an urge to vomit)

30-39:

Blood glucose decreased

40-49:

Blood glucose decreased
Blood glucose increased
Increased appetite
Diarrhoea
Dyspepsia (indigestion)
Eructation (release of gas from the digestive tract)
Nausea (feeling of having an urge to vomit)

50-59:

Injection site pain
Nausea (feeling of having an urge to vomit)
Blood glucose increased
Drug ineffective
Glycosylated haemoglobin increased
Malaise (a feeling of general discomfort or uneasiness)
Blood glucose decreased
Blood insulin increased
Injection site erythema (redness at injection site)
Multiple allergies (allergy to multiple agents)

60+:

Blood glucose increased
Drug ineffective
Weight increased
Ankle fracture
Back injury
Fall
Impaired healing
Joint injury
Lower limb fracture
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Type 2 Diabetes: 51 people, 60.00%
Diabetes: 18 people, 21.18%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and Mounjaro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously